1019O Clinical and translational data from the phase I SURPASS trial of ADP-A2M4CD8 T cell receptor (TCR) T cell therapy alone or combined with nivolumab in solid tumors

V. Moreno Garcia, Emiliano Calvo, Adam Asch, Marcus O. Butler, Jon Zugazagoitia, John A. Charlson, Andrés Cervantes, Brian A. Van Tine, David H. Aggen, Jade Clarke, Melissa L. Johnson, Megan Wileman, Andrew R. Liddle, R. Naidoo, Francine Brophy, M. J. Rosenberg, David A. Jolliffe, David E. Williams, E. Norry, David S. Hong